← Leaderboards
Jonathan P Celli
Massachusetts General Hospital
$3,483,846
Attributed
$6,510,917
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $989.8K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,510,917 · 5
By mechanism
UH3$2,729,559 · 1
U01$1,754,252 · 1
UH2$995,302 · 1
R00$708,113 · 1
K99$323,691 · 1
Top collaborators
- Tayyaba Hasan10 shared
- Rongguang Liang3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Tayyaba Hasan$21,611,486
- Jennifer Temel$9,010,566
- Sara Isabel Pai$12,404,338
- Brent K. Hollenbeck$12,084,917
- Shannon L Stott$3,615,955
Others in their field
Top investigators on “Optics”
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$425,121,299
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Francis L Halzen · University Of Wisconsin-Madison$212,820,462
- Ethan Schreier · Associated Universities, Inc.$206,468,864
- Demian A Bailey · Oregon State University$205,233,456
- Clare E Reimers · Gordon Research Conferences$205,233,456
Research focus
OpticsImageTechnologyTumorMalignant NeoplasmsTrainingDesignLightResponseCancer TherapyImaging TechnologyFluorescence ImagingReportingAreaResearch PersonnelTreatment ResponseBiological ModelsBaseIn VivoQuality Of LifeScreeningAwardOral LesionPuva Photochemotherapy
Grant awards (16)
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$549,428
U01 · FY2025 · CA · contact PI
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$537,737
U01 · FY2024 · CA
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$29,163
U01 · FY2024 · CA
A comprehensive platform for low-cost screening and image-guided photodynamic therapy (PDT) of pre-malignant and malignant oral lesions in low resource settings$637,924
U01 · FY2023 · CA
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$293,908
UH3 · FY2019 · CA
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$521,175
UH3 · FY2018 · CA
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$924,707
UH3 · FY2017 · CA
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$989,769
UH3 · FY2016 · CA
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$495,304
UH2 · FY2015 · CA
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology$237,851
R00 · FY2015 · CA · contact PI
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral$499,998
UH2 · FY2014 · CA
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology$236,272
R00 · FY2014 · CA · contact PI
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology$233,990
R00 · FY2013 · CA · contact PI
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology$144,019
K99 · FY2012 · CA · contact PI
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology$90,759
K99 · FY2011 · CA · contact PI
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology$88,913
K99 · FY2011 · CA · contact PI